Mobile app version of munafa.us
Login or Join
 Learn then Earn
stockMarketNEWS

 story : Blood clots as prevalent with Pfizer and Moderna vaccine as with AstraZeneca's: study #FinanceUSA #StockMarketNEWS A study by Oxford University found the number of people who receive blood clots after

@stockMarketNEWS Thu 15 Apr, 2021

Posted in: #FinanceUSA #StockMarketNEWS

Blood clots as prevalent with Pfizer and Moderna vaccine as with AstraZeneca's: study #FinanceUSA #StockMarketNEWS
A study by Oxford University found the number of people who receive blood clots after getting vaccinated with a coronavirus vaccine are about the same for those who get Pfizer and Moderna vaccines as they are for the AstraZeneca vaccine that was produced with the university's help. According to the study, 4 in 1 million people experience cerebral venous thrombosis after getting the Pfizer or Moderna vaccine, versus 5 in 1 million people for the AstraZeneca vaccine. The risk of getting CVT is much higher for those who get COVID-19 -- 39 in a million patients -- than it is for those for get vaccinated. AstraZeneca's vaccine use has been halted or limited in many countries on blood clot concerns.


Munafa USA Munafa India Munafa NSE


Report

Login to follow story

More posts by @stockMarketNEWS

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

Daily analysis, news, Munafa stocks list in email:

Back to top | Use Dark Theme